COVID-19 in India: Bharat Biotech's 'Covaxin' Gets Emergency Use Authorisation for Children Between 6-12 Years
The Drugs Controller General of India (DCGI) has given restricted emergency use authorisation to Bharat Biotech's 'Covaxin'.
Amid the ongoing surge in COVID-19 cases across the country, the Drugs Controller General of India (DCGI) has given restricted emergency use authorisation to Bharat Biotech's 'Covaxin' for children between the age of 6-12 years, report sources.
Check tweet:
#COVID19 | DCGI (Drugs Controller General of India) gives restricted emergency use authorisation to BharatBiotech's Covaxin for children between the age of 6-12 years: Sources
— ANI (@ANI) April 26, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)
(The above story first appeared on LatestLY on Apr 26, 2022 12:45 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
